Pseudomonas. Bacteria belonging to the
Pseudomonas group are common inhabitants of soil and water and can also be found on the surfaces of plants and animals.
Pseudomonas bacteria are found in nature in a biofilm or in planktonic form. In the latter form the single cell can display an extremely high motility due to its polar
More...flagella. Pseudomonas bacteria are renowned for their metabolic versatility as they can grow under a variety of growth conditions and do not need any organic growth factors. Typically they are plant pathogens, although several strains are pathogenic to humans. Pseudomonas aeruginosa. This organism is an opportunistic human pathogen. While it rarely infects healthy individuals, immunocompromised patients, like burn victims, AIDS-, cancer- or cystic fibrosis-patients are at increased risk for infection with this environmentally versatile bacteria. It is an important soil bacterium with a complex metabolism capable of degrading polycyclic aromatic hydrocarbons, and producing interesting, biologically active secondary metabolites including quinolones, rhamnolipids, lectins, hydrogen cyanide, and phenazines. Production of these products is likely controlled by complex regulatory networks making Pseudomonas aeruginosa adaptable both to free-living and pathogenic lifestyles. The bacterium is naturally resistant to many antibiotics and disinfectants, which makes it a difficult pathogen to treat. Less...- MuDoGeR: Multi-Domain Genome recovery from metagenomes made easy. Rocha U, et al. Mol Ecol Resour 2024 Feb
- Cross-contamination of carbapenem-resistant Gram-negative bacteria between patients and the hospital environment in the first year of a newly built surgical ward. Boutin S, et al. J Hosp Infect 2024 Feb
- First detection in Spain of NDM-1-producing Pseudomonas aeruginosa in two patients transferred from Ukraine to a university hospital. Hernández-García M, et al. J Glob Antimicrob Resist 2024 Mar
- Clinical, microbiological and genomic characterization of Gram-negative bacteria with dual carbapenemases as identified by rapid molecular testing. Mushtaq A, et al. JAC Antimicrob Resist 2024 Feb
- In-patient evolution of a high-persister Escherichia coli strain with reduced in vivo antibiotic susceptibility. Parsons JB, et al. Proc Natl Acad Sci U S A 2024 Jan 16
- Population-based genomic surveillance of Pseudomonas aeruginosa causing bloodstream infections in a large Canadian health region. Peirano G, et al. Eur J Clin Microbiol Infect Dis 2024 Mar
- Genome sequence generated by hybrid Nanopore-Illumina assembly of an extensively drug-resistant Pseudomonas aeruginosa strain from a keratitis outbreak. Calvario RC, et al. Microbiol Resour Announc 2024 Feb 15
- Genomic epidemiology and molecular characteristics of bla(NDM-1)-positive carbapenem-resistant Pseudomonas aeruginosa belonging to international high-risk clone ST773 in the Gauteng region, South Africa. Jung H, et al. Eur J Clin Microbiol Infect Dis 2024 Apr
- Cefiderocol heteroresistance associated with mutations in TonB-dependent receptor genes in Pseudomonas aeruginosa of clinical origin. Egge SL, et al. bioRxiv 2024 Jan 31
- Outbreak of Pseudomonas aeruginosa High-Risk Clone ST309 Serotype O11 Featuring bla(PER-1) and qnrVC6. Papa-Ezdra R, et al. Antibiotics (Basel) 2024 Feb 6
- Cataloging the phylogenetic diversity of human bladder bacterial isolates. Du J, et al. Genome Biol 2024 Mar 21
- Hospital wastewater as source of human pathogenic bacteria: A phenotypic and genomic analysis of international high-risk clone VIM-2-producing Pseudomonas aeruginosa ST235/O11. Zagui GS, et al. Environ Res 2024 Aug 15
- Antimicrobial Susceptibility and Molecular Features of Colonizing Isolates of Pseudomonas aeruginosa and the Report of a Novel Sequence Type (ST) 3910 from Thailand. Chukamnerd A, et al. Antibiotics (Basel) 2023 Jan 12
- Metagenome-assembled genomes indicate that antimicrobial resistance genes are highly prevalent among urban bacteria and multidrug and glycopeptide resistances are ubiquitous in most taxa. Magnúsdóttir S, et al. Front Microbiol 2023
- Optimal treatment of ceftazidime-avibactam and aztreonam-avibactam against bloodstream infections or lower respiratory tract infections caused by extensively drug-resistant or pan drug-resistant (XDR/PDR) Pseudomonas aeruginosa. Kang Y, et al. Front Cell Infect Microbiol 2023
- Involvement of Acquired Tobramycin Resistance in the Shift to the Viable but Non-Culturable State in Pseudomonas aeruginosa. Mangiaterra G, et al. Int J Mol Sci 2023 Jul 18
- Genomic dissection of endemic carbapenem resistance reveals metallo-beta-lactamase dissemination through clonal, plasmid and integron transfer. Macesic N, et al. Nat Commun 2023 Aug 8
- Direct prediction of carbapenem resistance in Pseudomonas aeruginosa by whole genome sequencing and metagenomic sequencing. Liu B, et al. J Clin Microbiol 2023 Nov 21
- The PitA protein contributes to colistin susceptibility in Pseudomonas aeruginosa. Erdmann MB, et al. PLoS One 2023
- Targeted deletion of Pf prophages from diverse Pseudomonas aeruginosa isolates impacts quorum sensing and virulence traits. Schmidt AK, et al. bioRxiv 2023 Nov 19
More...
Reference genome:  
Pseudomonas aeruginosa PAO1Human Pathogen Morphology: Gram:Negative, Shape:Bacilli, Motility:Yes Environment: OxygenReq:Aerobic, OptimumTemperature:25-30, TemperatureRange:Mesophilic, Habitat:Multiple Phenotype: Disease:Opportunistic infections |
Type
|
Name
|
RefSeq
|
INSDC
|
Size (Mb)
|
GC%
|
Protein
|
rRNA
|
tRNA
|
Other RNA
|
Gene
|
Pseudogene
|
|---|
| Chr | - | NC_002516.2 | AE004091.2 | 6.26 | 66.6 | 5,572 | 13 | 63 | 30 | 5,697 | 19 | |
|